Compare MLSS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | CLGN |
|---|---|---|
| Founded | 1989 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 18.4M |
| IPO Year | 1995 | N/A |
| Metric | MLSS | CLGN |
|---|---|---|
| Price | $0.25 | $1.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 297.3K | 20.4K |
| Earning Date | 11-13-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,929,517.00 | $2,475,000.00 |
| Revenue This Year | $8.95 | $1,596.12 |
| Revenue Next Year | $7.51 | $85.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.59 | ★ 280.77 |
| 52 Week Low | $0.22 | $1.30 |
| 52 Week High | $1.32 | $4.98 |
| Indicator | MLSS | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 35.46 | 47.17 |
| Support Level | $0.26 | $1.40 |
| Resistance Level | $0.30 | $1.99 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 35.80 | 42.37 |
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.